BE637363A - - Google Patents
Info
- Publication number
- BE637363A BE637363A BE637363DA BE637363A BE 637363 A BE637363 A BE 637363A BE 637363D A BE637363D A BE 637363DA BE 637363 A BE637363 A BE 637363A
- Authority
- BE
- Belgium
- Prior art keywords
- cellulose
- water
- soluble binder
- fibers
- paper
- Prior art date
Links
- 239000000835 fiber Substances 0.000 claims description 25
- 239000000126 substance Substances 0.000 claims description 25
- 229920002678 cellulose Polymers 0.000 claims description 23
- 239000001913 cellulose Substances 0.000 claims description 23
- 239000000203 mixture Substances 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 15
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 14
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 14
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 14
- 239000003232 water-soluble binding agent Substances 0.000 claims description 13
- 239000003814 drug Substances 0.000 claims description 10
- 239000011230 binding agent Substances 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-K 2qpq Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 5
- 229920003043 Cellulose fiber Polymers 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 4
- 239000010452 phosphate Substances 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 239000000969 carrier Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 229920002115 Sodium cellulose phosphate Polymers 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 7
- 238000003756 stirring Methods 0.000 description 6
- 229940079593 drugs Drugs 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 235000021395 porridge Nutrition 0.000 description 4
- 238000009827 uniform distribution Methods 0.000 description 4
- 239000001856 Ethyl cellulose Substances 0.000 description 3
- BJOIZNZVOZKDIG-MDEJGZGSSA-N Reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 3
- 230000000249 desinfective Effects 0.000 description 3
- -1 diethylamino-ethyl Chemical group 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 229920001249 ethyl cellulose Polymers 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000004898 kneading Methods 0.000 description 3
- 239000004922 lacquer Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2R,3R,4S,5R,6S)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2S,3R,4S,5R,6R)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2R,3R,4S,5R,6R)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin Chemical class CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 210000000936 Intestines Anatomy 0.000 description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N Methyl acetate Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 2
- 229960002900 Methylcellulose Drugs 0.000 description 2
- 229920001131 Pulp (paper) Polymers 0.000 description 2
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 229960003147 reserpine Drugs 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- NKCXQMYPWXSLIZ-PSRDDEIFSA-N (2S)-2-[[(2S)-1-[(2S)-5-amino-2-[[2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-hydroxybutanoyl]amino]propanoyl]amino]-4-oxobutanoyl]amino]-3-m Chemical compound O=C([C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(C)C)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O NKCXQMYPWXSLIZ-PSRDDEIFSA-N 0.000 description 1
- QOWAMIUFBNBINS-UHFFFAOYSA-N 2-[6-[4,5-diethoxy-2-(ethoxymethyl)-6-methoxyoxan-3-yl]oxy-4,5-dimethoxy-2-(methoxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)-5-methoxyoxane-3,4-diol Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(OC)C(OC)C(OC2C(C(O)C(OC)C(CO)O2)O)C(COC)O1 QOWAMIUFBNBINS-UHFFFAOYSA-N 0.000 description 1
- PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 description 1
- KPGABFJTMYCRHJ-YZOKENDUSA-N Ammonium alginate Chemical compound [NH4+].[NH4+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O KPGABFJTMYCRHJ-YZOKENDUSA-N 0.000 description 1
- 210000001772 Blood Platelets Anatomy 0.000 description 1
- GZDPBECKHIKSGX-UHFFFAOYSA-M C1(=CC=CC=C1)C(C(=O)[O-])OC1CCCCC1 Chemical compound C1(=CC=CC=C1)C(C(=O)[O-])OC1CCCCC1 GZDPBECKHIKSGX-UHFFFAOYSA-M 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229940105329 Carboxymethylcellulose Drugs 0.000 description 1
- JYGXADMDTFJGBT-VWUMJDOOSA-N Cortisol Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- CHNXZKVNWQUJIB-CEGNMAFCSA-N Ethisterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 CHNXZKVNWQUJIB-CEGNMAFCSA-N 0.000 description 1
- 229960000445 Ethisterone Drugs 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 229950003499 FIBRIN Drugs 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- 210000004051 Gastric Juice Anatomy 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229940088597 Hormone Drugs 0.000 description 1
- 210000004185 Liver Anatomy 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N Prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 229940005550 Sodium alginate Drugs 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 210000002784 Stomach Anatomy 0.000 description 1
- 229950006534 Syrosingopine Drugs 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive Effects 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 229960002478 aldosterone Drugs 0.000 description 1
- 229930013930 alkaloids Natural products 0.000 description 1
- 235000010407 ammonium alginate Nutrition 0.000 description 1
- 239000000728 ammonium alginate Substances 0.000 description 1
- 230000000844 anti-bacterial Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 125000002057 carboxymethyl group Chemical class [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- UZBQIPPOMKBLAS-UHFFFAOYSA-N diethylazanide Chemical compound CC[N-]CC UZBQIPPOMKBLAS-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229960004667 ethyl cellulose Drugs 0.000 description 1
- 235000010944 ethyl methyl cellulose Nutrition 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000000855 fungicidal Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002439 hemostatic Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- ZCDNRPPFBQDQHR-SSYATKPKSA-N methyl (1R,15S,17R,18R,19S,20S)-17-(4-ethoxycarbonyloxy-3,5-dimethoxybenzoyl)oxy-6,18-dimethoxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate Chemical compound C1=C(OC)C(OC(=O)OCC)=C(OC)C=C1C(=O)O[C@H]1[C@H](OC)[C@@H](C(=O)OC)[C@H]2C[C@@H]3C(NC=4C5=CC=C(OC)C=4)=C5CCN3C[C@H]2C1 ZCDNRPPFBQDQHR-SSYATKPKSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229920003087 methylethyl cellulose Polymers 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 229960004618 prednisone Drugs 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- MSXHSNHNTORCAW-UHFFFAOYSA-M sodium 3,4,5,6-tetrahydroxyoxane-2-carboxylate Chemical compound [Na+].OC1OC(C([O-])=O)C(O)C(O)C1O MSXHSNHNTORCAW-UHFFFAOYSA-M 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 200000000019 wound Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE637363A true BE637363A (pt) |
Family
ID=202930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE637363D BE637363A (pt) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE637363A (pt) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4136145A (en) * | 1974-07-05 | 1979-01-23 | Schering Aktiengesellschaft | Medicament carriers in the form of film having active substance incorporated therein |
| DK152172B (da) * | 1975-12-15 | 1988-02-08 | Hoffmann La Roche | Fremgangsmaade til fremstilling af en fast farmaceutisk enhedsdosisform |
| US4925670A (en) * | 1986-09-09 | 1990-05-15 | Desitin Arzneimittel Gmbh | Administration and dosage form for drug active agents, reagents or the like and process for the preparation thereof |
| DE4018247A1 (de) * | 1990-06-07 | 1991-12-12 | Lohmann Therapie Syst Lts | Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen |
| EP1306071A3 (en) * | 2001-10-24 | 2003-12-03 | Hewlett-Packard Company | A method and dosage form for dispensing a bioactive substance |
| EP1867321A2 (en) * | 2006-06-07 | 2007-12-19 | Familplan Consulting Ltd. | A pharmaceutical product adapted for oral transmucosal administration comprising a pharmaceutical agent |
| WO2008130764A1 (en) * | 2007-04-18 | 2008-10-30 | Colgate-Palmolive Company | Films comprising a plurality of polymers |
-
0
- BE BE637363D patent/BE637363A/fr unknown
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4136145A (en) * | 1974-07-05 | 1979-01-23 | Schering Aktiengesellschaft | Medicament carriers in the form of film having active substance incorporated therein |
| DK152172B (da) * | 1975-12-15 | 1988-02-08 | Hoffmann La Roche | Fremgangsmaade til fremstilling af en fast farmaceutisk enhedsdosisform |
| US4925670A (en) * | 1986-09-09 | 1990-05-15 | Desitin Arzneimittel Gmbh | Administration and dosage form for drug active agents, reagents or the like and process for the preparation thereof |
| DE4018247A1 (de) * | 1990-06-07 | 1991-12-12 | Lohmann Therapie Syst Lts | Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen |
| EP1582192A1 (en) * | 2001-10-24 | 2005-10-05 | Hewlett-Packard Company | A method and dosage form for dispensing a bioactive substance |
| EP1582191A1 (en) * | 2001-10-24 | 2005-10-05 | Hewlett-Packard Company | A method and dosage form for dispensing a bioactive substance |
| EP1306071A3 (en) * | 2001-10-24 | 2003-12-03 | Hewlett-Packard Company | A method and dosage form for dispensing a bioactive substance |
| EP1584318A2 (en) * | 2001-10-24 | 2005-10-12 | Hewlett-Packard Company | A method and dosage form for dispensing a bioactive substance |
| US6962715B2 (en) | 2001-10-24 | 2005-11-08 | Hewlett-Packard Development Company, L.P. | Method and dosage form for dispensing a bioactive substance |
| EP1584318A3 (en) * | 2001-10-24 | 2006-01-04 | Hewlett-Packard Company | A method and dosage form for dispensing a bioactive substance |
| US8454989B2 (en) | 2001-10-24 | 2013-06-04 | Hewlett-Packard Development Company, L.P. | Laminated ingestible dosage form for dispensing multiple bioactive substances |
| EP1867321A2 (en) * | 2006-06-07 | 2007-12-19 | Familplan Consulting Ltd. | A pharmaceutical product adapted for oral transmucosal administration comprising a pharmaceutical agent |
| EP1867321A3 (en) * | 2006-06-07 | 2008-11-19 | Familplan Consulting Ltd. | A pharmaceutical product adapted for oral transmucosal administration comprising a pharmaceutical agent |
| WO2008130764A1 (en) * | 2007-04-18 | 2008-10-30 | Colgate-Palmolive Company | Films comprising a plurality of polymers |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4308336B2 (ja) | ミクロフィブリル状微細繊維構造体およびその製造方法 | |
| KR100937625B1 (ko) | 가용성 웹 공극필름 및 이의 제조방법 | |
| KR0139107B1 (ko) | 조절된 방사된 섬유상 시스템 및 이의 제조방법 | |
| CN109641061B (zh) | 包含纤维素纳米纤维(cnf)以及包括闭孔的多孔固体材料药物载体 | |
| TW533083B (en) | Water soluble film for oral administration with instant wettability | |
| DE60210289T2 (de) | Atemerfrischender film | |
| FR2571253A1 (fr) | Preparation en forme de feuille | |
| US8632798B2 (en) | Cereal β glucan compositions, methods of preparation and uses thereof | |
| FR2596991A1 (fr) | Medicament sous forme liquide pour le traitement du psoriasis, a base de polymeres filmogenes | |
| US20050186257A1 (en) | Dissolvable film and method of manufacture | |
| JPS62178513A (ja) | シ−ト状口腔内貼付剤 | |
| FR2647343A1 (fr) | Nouvelle forme pharmaceutique poreuse et sa preparation | |
| BE637363A (pt) | ||
| EP2131823B9 (fr) | Film monocouche a desintegration rapide pour l'administration buccale de substances actives | |
| JP2003503320A (ja) | 抗ウィルス性を有するティシュ・ペーパー製品 | |
| JP2022515567A (ja) | 人工エクソソーム複合体の製造方法及び使用 | |
| JP3212270B2 (ja) | 葉たばこ抽出エキスを含有する熱不可逆凝固グルカンシートの製造方法および熱不可逆凝固グルカンシートを用いたたばこ香味発生媒体の製造方法 | |
| US11533929B2 (en) | Green tea film composition | |
| FR2661610A1 (fr) | Nouvelle forme lyophilisee de la diosmine et sa preparation. | |
| JP2001279596A (ja) | 水解紙及びその製造方法 | |
| FR2548537A1 (pt) | ||
| JP2006506448A (ja) | ペクチンフィルム | |
| FR2467873A1 (fr) | Pate adhesive protectrice pour utilisation dans les appareils d'ostomie | |
| EP0391754B1 (fr) | Composition pour favoriser la cicatrisation | |
| SK14302001A3 (sk) | Priľnavé prostriedky na umelý chrup obsahujúce kopolymér a terpolymér s izobutylénom alkylvinyléteru kyseliny maleínovej alebo jej anhydridu, prídavné priľnavé zložky, celulózové deriváty, nepriľnavú samonosnú vrstvu a spôsob ich použitia |